The new standard for cardiometabolic and cardiovascular disease risk assessment
Cardiovascular Engineering, Inc. is a leader in vascular diagnostics, dedicated to advancing cardiovascular health through innovative technologies. Our focus is on developing sophisticated tools for assessing arterial stiffness and hemodynamics, providing critical insights into vascular function and cardiovascular diseases. By partnering with researchers and clinicians, we strive to improve the understanding, prevention, and treatment of heart disease and vascular conditions. Our mission is to drive innovation in cardiovascular diagnostics, fostering healthier lives through better vascular health monitoring and care.
Our Partnerships
- Novartis
- Framingham Heart Study
- Harvard Medical School
- Boston University
- NIH
- Mayo Clinic
- Decode Genetics
- Albert Einstein College of Medicine
- National Institute on Aging
- Brigham and Womens Hospital
- Jackson Heart Study
- Hjartavernd